Veriti Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Veriti Management LLC

$0
Q4 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$1024.09 - $1201.76 $126,987 - $149,018	124 Added 3.34%	3,842 $4.04 Million
Q2 2024 Aug 02, 2024	BUY	$883.2 - $1071.19 $297,638 - $360,991	337 Added 9.97%	3,718 $3.91 Million
Q1 2024 Apr 19, 2024	BUY	$902.69 - $993.35 $87,560 - $96,354	97 Added 2.95%	3,381 $3.25 Million
Q4 2023 Feb 05, 2024	BUY	$775.18 - $881.7 $47,285 - $53,783	61 Added 1.89%	3,284 $2.88 Million
Q3 2023 Oct 27, 2023	BUY	$692.45 - $844.37 $29,775 - $36,307	43 Added 1.35%	3,223 $2.65 Million
Q2 2023 Jul 13, 2023	SELL	$700.03 - $830.35 $129,505 - $153,614	-185 Reduced 5.5%	3,180 $2.28 Million
Q1 2023 Apr 26, 2023	SELL	$680.49 - $826.97 $4,763 - $5,788	-7 Reduced 0.21%	3,365 $2.76 Million
Q4 2022 Jan 20, 2023	BUY	$705.89 - $766.39 $38,823 - $42,151	55 Added 1.66%	3,372 $0
Q3 2022 Oct 26, 2022	BUY	$573.97 - $724.32 $13,201 - $16,659	23 Added 0.7%	3,317 $2.29 Million
Q2 2022 Jul 18, 2022	SELL	$548.35 - $738.84 $81,704 - $110,087	-149 Reduced 4.33%	3,294 $1.95 Million
Q1 2022 Apr 11, 2022	SELL	$595.12 - $698.43 $80,341 - $94,288	-135 Reduced 3.77%	3,443 $2.41 Million
Q4 2021 Jan 19, 2022	SELL	$543.48 - $670.97 $45,652 - $56,361	-84 Reduced 2.29%	3,578 $2.26 Million
Q3 2021 Oct 08, 2021	BUY	$574.03 - $680.96 $136,045 - $161,387	237 Added 6.92%	3,662 $2.22 Million
Q2 2021 Jul 13, 2021	BUY	$472.8 - $558.54 $1.17 Million - $1.38 Million	2,474 Added 260.15%	3,425 $1.91 Million
Q1 2021 Apr 14, 2021	BUY	$446.73 - $548.2 $41,545 - $50,982	93 Added 10.84%	951 $450,000
Q4 2020 Feb 11, 2021	BUY	$478.3 - $607.98 $410,381 - $521,646	858 New	858 $415,000

Others Institutions Holding REGN

# of Institutions

1,500

Shares Held

83M

Call Options Held

1.22M

Put Options Held

1.5M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Veriti Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veriti Management LLC with notifications on news.

Account